United States · FDA National Drug Code directory
HYDROCHLOROTHIAZIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43353-240_e5f8cae3-76be-4f78-9b8a-690bacf28a09
- Product NDC
- 43353-240
- Form
- TABLET
- Composition / generic term
- HYDROCHLOROTHIAZIDE
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070301
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 45 TABLET in 1 BOTTLE, PLASTIC (43353-240-45) · 43353-240-45
- 90 TABLET in 1 BOTTLE, PLASTIC (43353-240-60) · 43353-240-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →